Harmony Biosciences Holdings, Inc.
HRMY
$27.85
-$0.52-1.83%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 158.69M | 185.68M | 180.90M | 152.72M | 145.49M |
| Total Depreciation and Amortization | 25.34M | 23.87M | 23.87M | 23.96M | 24.11M |
| Total Amortization of Deferred Charges | 647.00K | 659.00K | 673.00K | 686.00K | 700.00K |
| Total Other Non-Cash Items | 71.71M | 53.81M | 38.77M | 58.16M | 56.84M |
| Change in Net Operating Assets | 91.82M | 33.60M | 15.16M | -12.86M | -7.32M |
| Cash from Operations | 348.20M | 297.61M | 259.38M | 222.67M | 219.82M |
| Capital Expenditure | -310.00K | -716.00K | -648.00K | -1.28M | -1.15M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 0.00 | 0.00 | -33.07M | -33.07M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -39.34M | -28.49M | -23.02M | -24.59M | -33.26M |
| Cash from Investing | -39.65M | -29.20M | -23.67M | -58.94M | -67.48M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -16.25M | -15.00M | -15.00M | -15.00M | -15.00M |
| Issuance of Common Stock | 10.21M | 10.79M | 12.62M | 11.09M | 6.50M |
| Repurchase of Common Stock | -3.00M | -4.57M | -4.57M | -3.81M | -2.50M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -9.05M | -8.78M | -6.95M | -7.71M | -11.00M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 299.50M | 259.63M | 228.75M | 156.02M | 141.34M |